Term
| Simply put, what causes the release of neurotransmitters from a presynaptic vesicle? |
|
Definition
Depolarization of the cell
Note: the release of all neurotransmitters is calcium dependent |
|
|
Term
| Another name for neuromuscular junction |
|
Definition
|
|
Term
| Generally speaking what is the action of neurotransmitters |
|
Definition
They work to change the membrane potential of the postsynaptic cell by opening (or closing) ion channels
-Excitatory neurotransmitters
-inhibitory neurotransmitters |
|
|
Term
| Excitatory neurotransmitters involve which types of ions? |
|
Definition
-Ca2+
-Na+
Depolarization |
|
|
Term
| Inhibitory neurotrasmitters involve which type of ions? |
|
Definition
-K+
-Cl-
Hyperpolarization |
|
|
Term
| Describe ligand gated ion channels and give two examples |
|
Definition
They mediate the fast effects of neurotransmitters. The channel is closed during the reseting state and opens when the neurotransmitter binds.
ex: nicotinic cholinergic receptor
ex: GABA-A
ex:NMDA |
|
|
Term
| Describe G-protein linked receptors in respect to neurotransmitters |
|
Definition
Works like a hormone receptor, mediates slower effects of neurotransmitters. These receptors are present in peripheral tissue and in the brain
ex: adrenergic receptors
ex: dopamine receptors
ex: muscarinic cholinergic receptors
ex:opiate receptors |
|
|
Term
| Describe the location of acetylcholinesterase in the neuromuscular junction and in the brain |
|
Definition
Neuromuscular junction: sits in basal lamina
Brain: sits in postsynaptic membrane
both act in extracellular space |
|
|
Term
| What enzyme forms Acetylcholine? |
|
Definition
| choline-acetyltransferase |
|
|
Term
| What enzyme is used to breakdown Acetylcholine? |
|
Definition
|
|
Term
| Describe actylcholine synthesis |
|
Definition
Acetyl-Coa + choline in the presence of choline acetyltransferase = AcH
A high energy thioester bond is broken to form a lower energy ester bond |
|
|
Term
| Describe the action of acetylcholinesterase |
|
Definition
2-step rxn
1.The enzyme has a ser residue with an
-OH sidechain; -OH reacts with the substrate and binds the acetyl group = an acetyl enzyme intermediate (enzyme-ser-acetyl group) while the choline is already released
2. Intermediate undergoes a dehydration rxn.
|
|
|
Term
|
Definition
Curare blocks nicotinic receptors in the neuromuscular junction. This would block AcH binding, thus it has an antagonistic effect. causes flacid paralysis. |
|
|
Term
| What do atropine and scopolamine do? |
|
Definition
| They block muscarinic receptors |
|
|
Term
| What do Oraganophosphates do? |
|
Definition
Organophosphates inhibit acetylcholinesterase, irreversibly by acting on the ser residue of the active site.
They are often used as pesticides or chem. warfare |
|
|
Term
| Generally, how are biogenic amines formed?What is their charge? What is their purpose? |
|
Definition
Formed from aromatic amino acids by decarboxylation
They carry a positive charge at ph=7
They are used as neurotransmitters, paracrine messengers, and hormones |
|
|
Term
| What is the precursor for catecholamines? |
|
Definition
|
|
Term
| What is the precursor for indoleamines? |
|
Definition
|
|
Term
| What is the precursor for histamine |
|
Definition
|
|
Term
| What is the rate limiting/committed step of the catecholamine synthesis pathway? |
|
Definition
tyrosine ydroxylase, which works to attach a new -OH group to tyrosine
[image] |
|
|
Term
| What are the three major products of catecholamine synthesis ? |
|
Definition
1. dopamine
2. norepinephrine
3. epinephrine |
|
|
Term
| What is the necessary coenzyme for tryosine hydroxylase in catecholamine synthesis? |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| What is the important cofactor in catecholamine synthesis when L-Dopa is converted to Dopamine via DOPA decarboxylase? |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Describe what is occuring when going from Norepinephrine to epinephrine |
|
Definition
A methyl group is attached to the amine group. via conversion of:
SAM-SAH
(universal methyl donor for biochem rxns) |
|
|
Term
|
Definition
|
|
Term
| List all substrates and enzymes in order for the synthesis of catecholamines |
|
Definition
-L tyrosine
-tyrosine hydroxylase (BiO4=cofactor, -OH group added)
-L DOPA
-Dopa decarboxylase (B6=cofactor, remove CO2, amine group added)
-Dopamine
-Cu+, ascorbate (another -OH group added)
-norephinephrine
-SAM-Sah
-epinephrine
[image] |
|
|
Term
| Which enzyme in the catecholamine synthesis pathway is feedback inhibited by the amines? |
|
Definition
|
|
Term
| how are catecholamines inactivated? |
|
Definition
First they are taken up back into the nerve via: high affinity sodium cotransport uptake
This is followed by inactivation.
1. MAO (deamination)
2. COMT (methylation) |
|
|
Term
| Describe the inactivation of norepinephrine |
|
Definition
MAO and COMT are both involved in the inactivation of norepinephrine. It can follow two pathways, where MAO acts followed by COMT or COMT and then MAO
1. norepinephrine
MAO- deamination, to perform this FADH2 must be converted to FAD, however, the toxic byproduct produced is H2O2
COMT- acts to methylate
2. COMT and SAM- methylate
MAO- deamination
Both pathways result in the same product |
|
|
Term
| Aldehyde groups in the body are not stable, what are they usually oxidized to in the body |
|
Definition
|
|
Term
| What is the most important indolamine? |
|
Definition
|
|
Term
| When the cofactor BiOH4 is used what happens? |
|
Definition
| Attaches an -OH group to an aromatic ring |
|
|
Term
| Describe the synthesis of indoleamines (maletonin) |
|
Definition
step 1: tryptophan hydroxylase: BioH4, NADPH converted to NADP+
step 2: Decarboxylase: B6
step 3: acetyl group attached to the nitrogen
step 4: sam: attaches methyl group
[image] |
|
|
Term
| What is the degradation product of dopamine, how is dopamine degraded? |
|
Definition
Homovanillic acid: degraded using MAO B
[image] |
|
|
Term
| What is the degradation product of epinephrine and norepinephrine? |
|
Definition
vanillymandelic acid: MAO and COMT
[image] |
|
|
Term
| What is the degredation product of 5-HT? |
|
Definition
5-hydroxyindolacetic acid: MAO A
[image] |
|
|
Term
| How are the degradation products of dopamine, epinephrine/norepinephrin, and 5-HT excreted? |
|
Definition
|
|
Term
| MAO-inhibitors are often used as which type of pharmaceutical? |
|
Definition
antidepressents
Side effect: hypertensive crisis after exposure to foods containing tyramine (cheese, red wine)
not commonly prescribed |
|
|
Term
| A patient is on an MAO-inhibitor to treat depression. Which foods should you advise the patient not to eat? |
|
Definition
| Any foods with tyramine including wine and cheese will cause hypertensive crisis as a side effect |
|
|
Term
| MAO-A degrades what bioamine? |
|
Definition
|
|
Term
| MAO-B degrades which bioamine? |
|
Definition
|
|
Term
| Which bioamine is degraded by both MAO A and MAO B? |
|
Definition
|
|
Term
| Which bioamine is not degraded by MAO at all? |
|
Definition
|
|
Term
| Describe parkinsons disease? |
|
Definition
| age related neurodegenerative disease with degeneration of nigro-striatal dopamine neurons in the brain due to lack of dopamine. |
|
|
Term
| Why can't dopamine be administered as treatment for Parkinsons disease? |
|
Definition
Because Dopamine is rapidly inactivated by MAOB |
|
|
Term
| Why is L DOPA the last resort administered drug in the treatment of Parkinsons disease? |
|
Definition
The production of L-DOPA involves the production of H2O2 which is a toxic byproduct. It is a good drug because it can cross the blood brain barrier.
Note: L DOPA is often administered with carbidopa which prevents L dopa from being decarboxylated |
|
|
Term
| Which MAO-B inhibitor can be used to treat parkinsons disease? |
|
Definition
|
|
Term
| Why would an MAO B inhibitor be useful in treating Parkinsons disease? |
|
Definition
| Because parkinsons disease involves the lack of dopamine in the brain. So administering an MAO B inhibitor would be great, since MAO B is essential for the degredation of dopamine. |
|
|
Term
| Can an anticholinergic be administered for treatment of parkinsons disease? |
|
Definition
|
|